The largest number of people who were administrated the COVID-19 vaccine in the Gulf Cooperation Council (GCC) countries in February 2021 was in the United Arab Emirates (UAE) at 9.7 thousand per one million population.

In 2024, after two years of decline, there was significant growth in shipments abroad of vaccines for human medicine, when their volume increased by X% to X tons. Over the period under review, exports, however, showed a abrupt shrinkage. The growth pace was the most rapid in 2021 when exports increased by X%. The volume of export peaked at X tons in 2017; however, from 2018 to 2024, the exports remained at a lower figure.

The United Arab Emirates (UAE) had the highest number of COVID-19 vaccine doses administered at about 134.63 doses per 100 people in June 2021 among other Gulf Cooperation Council (GCC) countries. Among other Gulf Cooperation Council (GCC) countries, Qatar was the only country with a positive fiscal balance before the COVID-19 pandemic.

This statistic displays the value of vaccine imports from Saudi Arabia to the Gulf Cooperation Council from 2011 to 2015. In 2015, the value of vaccine imports from Saudi Arabia to the GCC region was about eight million Saudi Arabian Riyal.

GCC Therapeutic Vaccines Market is poised for substantial growth, driven by technological advancements, increasing incidences of chronic diseases.

In 2024, the GCC veterinary medicine vaccines market increased by 12% to $208M, rising for the fourth year in a row after three years of decline. The market value increased at an average annual rate of +5.6% from 2012 to 2024; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Over the period under review, the market reached the peak level in 2024 and is expected to retain growth in years to come.

Die Marktgröße und der Anteil sind kategorisiert nach Type of Vaccine (BCG Vaccine, Recombinant Vaccines, DNA Vaccines, Live Attenuated Vaccines) and End-User (Hospitals, Clinics, Research Institutions, Pharmaceutical Companies, Government Agencies) and Distribution Channel (Direct Sales, Distributors, Online Sales, Pharmacies, Hospitals) and geografischen Regionen (Nordamerika, Europa, Asien-Pazifik, Südamerika, Naher Osten & Afrika)

The Middle-East And Africa Cancer Vaccines Market report segments the industry into By Technology (Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines, Viral Vector And DNA Cancer Vaccines, Other Technologies), By Treatment Method (Preventive Vaccine, Therapeutic Vaccine), By Application (Prostate Cancer, Cervical Cancer, Other Applications), and Geography (GCC, South Africa, Rest Of Middle East And Africa).

El tamaño y participación del mercado se clasifica según Type of Vaccine (Inactivated Flu Vaccine, Live Attenuated Flu Vaccine) and Route of Administration (Intramuscular, Intranasal) and End User (Hospitals, Clinics, Pharmacies, Homecare Settings, Others) and Age Group (Pediatric, Adult, Geriatric) and Distribution Channel (Direct Sales, Retail Pharmacy, Online Pharmacy) and regiones geográficas (Norteamérica, Europa, Asia-Pacífico, Sudamérica, Oriente Medio y África)

O tamanho e a participação do mercado são categorizados com base em Type of Vaccine (Inactivated Flu Vaccine, Live Attenuated Flu Vaccine) and Route of Administration (Intramuscular, Intranasal) and End User (Hospitals, Clinics, Pharmacies, Homecare Settings, Others) and Age Group (Pediatric, Adult, Geriatric) and Distribution Channel (Direct Sales, Retail Pharmacy, Online Pharmacy) and regiões geográficas (América do Norte, Europa, Ásia-Pacífico, América do Sul, Oriente Médio e África)

La dimensione e la quota del mercato sono classificate in base a Vaccine Type (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)) and Age Group (Infants (0-1 years), Children (1-5 years), Adults) and Distribution Channel (Hospitals, Clinics, Pharmacies, Public Health Organizations, Non-Governmental Organizations (NGOs)) and regioni geografiche (Nord America, Europa, Asia-Pacifico, Sud America, Medio Oriente e Africa)

この市場の規模とシェアは、次の基準で分類されます： Type of Vaccine (BCG Vaccine, Recombinant Vaccines, DNA Vaccines, Live Attenuated Vaccines) and End-User (Hospitals, Clinics, Research Institutions, Pharmaceutical Companies, Government Agencies) and Distribution Channel (Direct Sales, Distributors, Online Sales, Pharmacies, Hospitals) and 地域別（北米、欧州、アジア太平洋、南米、中東およびアフリカ）

According to a survey on the digital transformation post the COVID-19 pandemic in the Middle East and North Africa (MENA) region in 2021, 83 percent of respondents transformed to remote working and meetings. The number of people who were administrated the COVID-19 vaccine in the Gulf Cooperation Council (GCC) countries in February 2021 was in the United Arab Emirates (UAE) at 9.7 thousand per one million population.

この市場の規模とシェアは、次の基準で分類されます： Type of Vaccine (Inactivated Flu Vaccine, Live Attenuated Flu Vaccine) and Route of Administration (Intramuscular, Intranasal) and End User (Hospitals, Clinics, Pharmacies, Homecare Settings, Others) and Age Group (Pediatric, Adult, Geriatric) and Distribution Channel (Direct Sales, Retail Pharmacy, Online Pharmacy) and 地域別（北米、欧州、アジア太平洋、南米、中東およびアフリカ）

تم تصنيف حجم وحصة السوق حسب Type of Vaccine (Inactivated Flu Vaccine, Live Attenuated Flu Vaccine) and Route of Administration (Intramuscular, Intranasal) and End User (Hospitals, Clinics, Pharmacies, Homecare Settings, Others) and Age Group (Pediatric, Adult, Geriatric) and Distribution Channel (Direct Sales, Retail Pharmacy, Online Pharmacy) and المناطق الجغرافية (أمريكا الشمالية، أوروبا، آسيا والمحيط الهادئ، أمريكا الجنوبية، الشرق الأوسط وأفريقيا)